galactose has been researched along with Lymphoma, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, X; Gao, J; Han, X; Liu, C; Ouyang, X; Qiu, Y; Su, W; Tong, X; Xu, M; Yun, F; Yun, MM; Yun, S; Zhao, H; Zhao, R; Zhou, E | 1 |
| Kijimoto-Ochiai, S; Uede, T | 1 |
1 trial(s) available for galactose and Lymphoma, B-Cell
| Article | Year |
|---|---|
Combination of cytokine-induced killer and dendritic cells pulsed with antigenic α-1,3-galactosyl epitope-enhanced lymphoma cell membrane for effective B-cell lymphoma immunotherapy.
Topics: Adult; Aged; Animals; Antigens, Neoplasm; Cancer Vaccines; Cattle; Cell Membrane; Cytokine-Induced Killer Cells; Cytotoxicity, Immunologic; Dendritic Cells; Epitopes; Female; Flow Cytometry; Galactose; Humans; Immunotherapy; Interferon-gamma; Lymphocyte Subsets; Lymphocytes; Lymphoma, B-Cell; Male; Middle Aged; Treatment Outcome | 2016 |
1 other study(ies) available for galactose and Lymphoma, B-Cell
| Article | Year |
|---|---|
CD23 molecule acts as a galactose-binding lectin in the cell aggregation of EBV-transformed human B-cell lines.
Topics: alpha-Fetoproteins; Antibodies, Monoclonal; Asialoglycoproteins; B-Lymphocytes; beta-Galactosidase; Cell Aggregation; Cell Line, Transformed; Fetuins; Flow Cytometry; Galactose; Glycoproteins; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Neuraminidase; Receptors, IgE; Sepharose; Tumor Cells, Cultured | 1995 |